Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
Clinical trial NCT05423769 · COMPLETED
Trial details
- NCT number
- NCT05423769
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-19
- Primary completion
- 2023-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.